MiR-504-3p Has Tumor-Suppressing Activity and Decreases IFITM1 Expression in Non-Small Cell Lung Cancer Cells
出版年份 2022 全文链接
标题
MiR-504-3p Has Tumor-Suppressing Activity and Decreases IFITM1 Expression in Non-Small Cell Lung Cancer Cells
作者
关键词
-
出版物
Genetic Testing and Molecular Biomarkers
Volume 26, Issue 7-8, Pages 351-359
出版商
Mary Ann Liebert Inc
发表日期
2022-08-27
DOI
10.1089/gtmb.2021.0158
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Lung Cancer 2020
- (2020) Brett C. Bade et al. CLINICS IN CHEST MEDICINE
- Deciphering the Roles of IFITM1 in Tumors
- (2020) Renba Liang et al. Molecular Diagnosis & Therapy
- Interferon-Induced Transmembrane Protein 1 (IFITM1) Promotes Distant Metastasis of Small Cell Lung Cancer
- (2020) Shuichi Sakamoto et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Opposing activities of IFITM proteins in SARS‐CoV‐2 infection
- (2020) Guoli Shi et al. EMBO JOURNAL
- Rapid interferon independent expression of IFITM3 following T cell activation protects cells from influenza virus infection
- (2019) James G. Bedford et al. PLoS One
- MicroRNA‑504 targets AEG‑1 and inhibits cell proliferation and invasion in retinoblastoma
- (2019) Lina Wang et al. Molecular Medicine Reports
- Inhibiting of Proliferation, Migration, and Invasion in Lung Cancer Induced by Silencing Interferon-Induced Transmembrane Protein 1 (IFITM1)
- (2019) Jun Yan et al. Biomed Research International
- Cancer Progress and Priorities: Lung Cancer
- (2019) Matthew B. Schabath et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- The IFITM protein family in adaptive immunity
- (2019) Diana C. Yánez et al. IMMUNOLOGY
- Deciphering miRNAs’ Action through miRNA Editing
- (2019) Marta Correia de Sousa et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MiR-504 inhibits cell proliferation and invasion by targeting LOXL2 in non small cell lung cancer
- (2018) Ming-fan Ye et al. BIOMEDICINE & PHARMACOTHERAPY
- MiRNA-based Therapeutics for Lung Cancer
- (2018) Miaowei Wu et al. CURRENT PHARMACEUTICAL DESIGN
- Role of miRNA in Lung Cancer-Potential Biomarkers and Therapies
- (2018) Xiaohong Du et al. CURRENT PHARMACEUTICAL DESIGN
- Upregulation of PITX2 Promotes Letrozole Resistance via Transcriptional Activation of IFITM1 Signaling in Breast Cancer Cells
- (2018) Ying-ying Xu et al. Cancer Research and Treatment
- MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling
- (2018) Hui Quan et al. BIOMEDICINE & PHARMACOTHERAPY
- MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance
- (2018) Mohammad Askandar Iqbal et al. MOLECULAR ASPECTS OF MEDICINE
- Interferon‐induced transmembrane protein 1‐mediated EGFR/SOX2 signaling axis is essential for progression of non‐small cell lung cancer
- (2018) Ying‐Gui Yang et al. INTERNATIONAL JOURNAL OF CANCER
- DDR2 and IFITM1 Are Prognostic Markers in Gallbladder Squamous Cell/Adenosquamous Carcinomas and Adenocarcinomas
- (2017) Daiqiang Li et al. PATHOLOGY & ONCOLOGY RESEARCH
- Reduced miR-105-1 levels are associated with poor survival of patients with non‑small cell lung cancer
- (2017) Gaixia Lu et al. Oncology Letters
- A tumor-suppressive microRNA, miR-504, inhibits cell proliferation and promotes apoptosis by targeting FOXP1 in human glioma
- (2016) Run Cui et al. CANCER LETTERS
- miR-127 promotes EMT and stem-like traits in lung cancer through a feed-forward regulatory loop
- (2016) L Shi et al. ONCOGENE
- Interferon-induced transmembrane protein 1 (IFITM1) is required for the progression of colorectal cancer
- (2016) Ita Novita Sari et al. Oncotarget
- IFITM1 promotes the metastasis of human colorectal cancer via CAV-1
- (2015) Fang Yu et al. CANCER LETTERS
- Growth inhibitory effects of miR-221 and miR-222 in non-small cell lung cancer cells
- (2015) Ryo Yamashita et al. Cancer Medicine
- Editorial (Thematic Issue: “miRNA and Cancer; Computational and Experimental Approaches”)
- (2014) Yusuf Tutar CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- microRNA-504 inhibits cancer cell proliferation via targeting CDK6 in hypopharyngeal squamous cell carcinoma
- (2014) NAOKO KIKKAWA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- IFITM-Family Proteins: The Cell's First Line of Antiviral Defense
- (2014) Charles C. Bailey et al. Annual Review of Virology
- Enhanced survival of lung tissue-resident memory CD8+ T cells during infection with influenza virus due to selective expression of IFITM3
- (2013) Linda M Wakim et al. NATURE IMMUNOLOGY
- Overexpression of IFITM1 Has Clinicopathologic Effects on Gastric Cancer and Is Regulated by an Epigenetic Mechanism
- (2012) Jieun Lee et al. AMERICAN JOURNAL OF PATHOLOGY
- Identification of genes involved in radioresistance of nasopharyngeal carcinoma by integrating gene ontology and protein-protein interaction networks
- (2011) Xiao-Dong Zhu INTERNATIONAL JOURNAL OF ONCOLOGY
- Characterization of the osteoblast-specific transmembrane protein IFITM5 and analysis of IFITM5-deficient mice
- (2010) Nobutaka Hanagata et al. JOURNAL OF BONE AND MINERAL METABOLISM
- The widespread regulation of microRNA biogenesis, function and decay
- (2010) Jacek Krol et al. NATURE REVIEWS GENETICS
- The angiogenic switch in carcinogenesis
- (2009) Vanessa Baeriswyl et al. SEMINARS IN CANCER BIOLOGY
- MicroRNAs in Cancer
- (2008) Yong Sun Lee et al. Annual Review of Pathology-Mechanisms of Disease
- IFN-Induced Transmembrane Protein 1 Promotes Invasion at Early Stage of Head and Neck Cancer Progression
- (2008) H. Hatano et al. CLINICAL CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now